310 related articles for article (PubMed ID: 7514955)
1. Protection of thyroid cancer cells by complement-regulatory factors.
Yamakawa M; Yamada K; Tsuge T; Ohrui H; Ogata T; Dobashi M; Imai Y
Cancer; 1994 Jun; 73(11):2808-17. PubMed ID: 7514955
[TBL] [Abstract][Full Text] [Related]
2. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
[TBL] [Abstract][Full Text] [Related]
3. Expression of complement regulating factors in gastric cancer cells.
Inoue T; Yamakawa M; Takahashi T
Mol Pathol; 2002 Jun; 55(3):193-9. PubMed ID: 12032231
[TBL] [Abstract][Full Text] [Related]
4. The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues.
Thorsteinsson L; O'Dowd GM; Harrington PM; Johnson PM
APMIS; 1998 Sep; 106(9):869-78. PubMed ID: 9808413
[TBL] [Abstract][Full Text] [Related]
5. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
[TBL] [Abstract][Full Text] [Related]
6. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
[TBL] [Abstract][Full Text] [Related]
7. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of multiple regulators of complement activation in autoimmune thyroid disease.
Tandon N; Yan SL; Morgan BP; Weetman AP
Immunology; 1994 Apr; 81(4):643-7. PubMed ID: 7518800
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of CD46, CD55, and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies.
Gelderman KA; Blok VT; Fleuren GJ; Gorter A
Lab Invest; 2002 Apr; 82(4):483-93. PubMed ID: 11950905
[TBL] [Abstract][Full Text] [Related]
10. Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion.
Närkiö-Mäkelä M; Jero J; Meri S
Clin Exp Immunol; 1999 Jun; 116(3):401-9. PubMed ID: 10361226
[TBL] [Abstract][Full Text] [Related]
11. Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma.
Weng WK; Levy R
Blood; 2001 Sep; 98(5):1352-7. PubMed ID: 11520782
[TBL] [Abstract][Full Text] [Related]
12. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
[TBL] [Abstract][Full Text] [Related]
13. Complement-regulatory proteins in ovarian malignancies.
Bjørge L; Hakulinen J; Wahlström T; Matre R; Meri S
Int J Cancer; 1997 Jan; 70(1):14-25. PubMed ID: 8985085
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium.
Koretz K; Brüderlein S; Henne C; Möller P
Br J Cancer; 1993 Nov; 68(5):926-31. PubMed ID: 7692919
[TBL] [Abstract][Full Text] [Related]
15. Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes.
Taylor CT; Johnson PM
Mol Hum Reprod; 1996 Jan; 2(1):52-9. PubMed ID: 9238658
[TBL] [Abstract][Full Text] [Related]
16. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
D'Cruz OJ; Haas GG
Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
[TBL] [Abstract][Full Text] [Related]
17. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
18. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
19. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
Iborra A; Mayorga M; Llobet N; Martínez P
Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.
Okada M; Yoshioka K; Takemura T; Akano N; Aya N; Murakami K; Maki S
Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):367-73. PubMed ID: 8322453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
